Fish Oil, Green Tea, and Prostate Cancer Prevention

Article

Fatty acid synthase (FAS) is a lipogenic multienzyme that catalyzes the final step in de novo fatty acid synthesis. Recently, FAS has been characterized as an oncogene and is overexpressed in various tumor types including prostate. FAS expression does not appear to be regulated by nutritional controls. However, when omega-3 fatty acid (w-3 FA) and docosahexanoic acid (DHA) are added, FAS expression appears to be inhibited.

To view research abstract, click here.

Related Videos
Insight on the Promising 52-Week KarXT Data with Rishi Kakar, MD
Jonathan Barratt, MD | Credit: IgA Nephropathy Foundation
HCPLive Five at ACC 2024 | Image Credit: HCPLive
Jonathan Barratt, MD | Credit: IgA Nephropathy Foundation
Sunny Rai, PhD: “I” Language Markers Do Not Detect Depression in Black Individuals
Ankeet Bhatt, MD, MBA | Credit: X.com
© 2024 MJH Life Sciences

All rights reserved.